Benefit-risk evaluation in drug licensing decisions: current European status

Activity: Talk and presentationProfessional or public presentationProfessional

Description

Presentation/workshop during SIR European Regulatory Affairs (ERA) course
Period17-Jan-2018
Held atSIR Institute for Pharmacy Practice and Policy, Netherlands
Degree of RecognitionNational